Federated Hermes
IMUX icon

Federated Hermes’s Immunic IMUX Stock Holding History

Federated Hermes’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-61
Closed -$921 – 2080
2023
Q4 		$921 Buy
+61
New +$747 ﹤0.01% 1978
2021
Q1 		– Sell
-2,436
Closed -$373K – 2282
2020
Q4 		$373K Buy
2,436
+2,431
+48,620% +$437K ﹤0.01% 1598
2020
Q3 		$1K Buy
+5
New +$819 ﹤0.01% 2160
2016
Q3 		– Hold
0
– -$1K – 2137
2016
Q2 		– Hold
0
– – – 2038

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Federated Hermes's IMUX Position: Q1 2024 in Review

Federated Hermes sold out of Immunic (IMUX) in Q1 2024, closing a stake of 61 shares — an estimated $921 sold.

Federated Hermes first reported a position in IMUX in Q3 2020 and held it in 3 quarters. The position peaked at $373K in Q4 2020. 59 funds tracked by Wall St. Rank hold IMUX as of Q1 2024.

  • Federated Hermes reported no remaining Immunic position as of Q1 2024 after selling out during the quarter.
  • Federated Hermes sold 61 Immunic shares in Q1 2024, an estimated $921.
  • Federated Hermes first reported a position in Immunic in Q3 2020 and held it in 3 quarters.
  • Federated Hermes's Immunic position peaked at $373K in Q4 2020.
  • 59 funds tracked by Wall St. Rank held Immunic as of Q1 2024.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.